Acute hepatitis due to Shen-Min: A herbal product derived from Polygonum multiflorum

Journal of Clinical Gastroenterology

Volumn 40, Issue 7, 2006, Pages 629-632

  Cárdenas, Andrés ^a,c   Restrepo, Juan Carlos ^a   Sierra, Fernando ^b   Correa, Gonzalo ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Drug induced liver disease; Hair supplement; Hepatitis; Hepatotoxicity; Herbal products; Liver failure; Polygonum multiflorum; Shen Min

Indexed keywords

HERBACEOUS AGENT; POLYGONUM MULTIFLORUM EXTRACT; SHEN MIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HAIR GROWTH; HUMAN; JAUNDICE; LIVER INJURY; PLANT ROOT; POLYGONUM; POLYGONUM MULTIFLORUM; PRIORITY JOURNAL; RASH;

ACUTE DISEASE; ADULT; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HAIR PREPARATIONS; HEPATITIS, TOXIC; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER; POLYGONUM;

EID: 33747480564     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200608000-00014     Document Type: Article

References (17)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
2. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wupian manufactured from Polygonum multiflorum. Vet Hum Toxicol. 1996;38:280-282.
3. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol. 2001;16:115-117.
4. Mazzanti G, Batinelli L, Daniele C, et al. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med. 2004;140:W30.
5. Stedman C. Herbal hepatotoxicity. Semin Liver Dis. 2002;22:195-206.
6. Willet KL, Roth RA, Walker L. Workshop overview: hepatotoxicity assessment for botanical dietary supplements. Toxicol Sci. 2004;79:4-9.
7. Maddrey W. Drug-induced hepatotoxicity 2005. J Clin Gastroenterol. 2005;39:S83-S89.
8. Geubel AP, De Galocsy C, Alves N, et al. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology. 1991;100:1701-1709.
9. Chitturi S, Farrell GC. Drug-induced liver injury. In: Schiff E, Sorrel M, Maddrey W, eds. Schiff's Diseases of The Liver. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003:1059-1128.
10. Parra JL, Reddy KR. Hepatotoxicity of hypolipidemic drugs. Clin Liver Dis. 2003;7:415-433.
11. Stickel F, Patsenker E, Schuppan D. Herbal hepatoxicity. J Hepatol. 2005;43:901-910.
12. Neuberger J. Prediction of survival for patients with fulminant hepatic failure. Hepatology. 2005;41:19-22.
13. Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology. 2001;33:308-310.
14. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin Epidemiol. 1993;46:1323-1330.
15. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664-669.
16. Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol. 2000;33:949-952.
17. Sierra F, Torres D. A concise and structured review of drug-induced toxic hepatic disease. Ann Hepatol. 2004;3:18-25.